EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibitory Impact of the Amino Benzoic Derivative DAB-2-28 on the Process of Epithelial–Mesenchymal Transition in Human Breast Cancer Cells

Laurie Fortin iD, Julie Girouard, Yassine Oufqir, Alexis Paquin iD, Francis Cloutier, Isabelle Plante iD, Gervais Bérubé iD, Carlos Reyes-Moreno iD

Molecules · 2025

DOI: 10.3390/molecules30153284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Laurie Fortin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Groupe de Recherche en Signalisation Cellulaire (GRSC), Département de Biologie Médicale, Université du Québec à Trois-Rivières, Trois-Rivières, QC G…. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research Society and the Canadian Institutes of Health Research, Cancer Research Society, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macrophage-mediated inflammation is known to be involved in the epithelial–mesenchymal transition (EMT) of various types of cancer. This makes macrophage-derived inflammatory factors prime targets for the development of new treatments. This study uncovers the therapeutic potential and action mechanism of DAB-2-28, a small-molecule derived from para-aminobenzoic acid, in the treatment of breast cancer. The luminal MCF-7 and the triple-negative MDA-MB-231 cancer cell lines used in this study represent, respectively, breast cancers in which the differentiation states are related to the epithelial phenotype of the mammary gland and breast cancers expressing a highly aggressive mesenchymal phenotype. In MCF-7 cells, soluble factors from macrophage-conditioned media (CM-MØ) induce a characteristic morphology of mesenchymal cells with an upregulated expression of Snail1, a mesenchymal marker, as opposed to a decrease in the expression of E-cadherin, an epithelial marker. DAB-2-28 does not affect the differential expression of Snail1 and E-cadherin in response to CM-MØ, but negatively impacts other hallmarks of EMT by decreasing invasion and migration capacities, in addition to MMP9 expression and gelatinase activity, in both MCF-7 and MDA-MB-231 cells. Moreover, DAB-2-28 inhibits the phosphorylation of key pro-EMT transcriptional factors, such as NFκB, STAT3, SMAD2, CREB, and/or AKT proteins, in breast cancer cells exposed to different EMT inducers. Overall, our study provides evidence suggesting that inhibition of EMT initiation or maintenance is a key mechanism by which DAB-2-28 can exert anti-tumoral effects in breast cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionBreast NeoplasmsAntineoplastic AgentsHumansFemaleCell MovementCell Line, TumorMCF-7 CellsGene Expression Regulation, NeoplasticMatrix Metalloproteinase 9CadherinsMacrophagesSnail Family Transcription FactorsSignal TransductionCulture Media, Conditioned

Stichwörter der Autor:innen

inflammationluminal breast cancermacrophagespara-aminobenzoic acid (PABA)small moleculestriple-negative breast cancer

Substanzen

Matrix Metalloproteinase 9CadherinsSnail Family Transcription FactorsAntineoplastic AgentsCulture Media, Conditioned

Autor:innen und Institutionen

  • Groupe de Recherche en Signalisation Cellulaire (GRSC), Département de Biologie Médicale, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.
  • Regroupement Intersectoriel de Recherche en Santé de l'Université du Québec (RISUQ), Université du Québec, Québec, QC G1K 9H7, Canada.
  • Groupe de Recherche en Signalisation Cellulaire (GRSC), Département de Chimie, Biochimie et Physique, Université du Québec à Trois-Rivières, Trois-Rivières, QC G8Z 4M3, Canada.
  • Institut National de la Recherche Scientifique (INRS)-Centre Armand Frappier Santé Biotechnologie, Laval, QC H7V 1B7, Canada.

ORCID-Profile: Laurie Fortin, Alexis Paquin, Isabelle Plante, Gervais Bérubé, Carlos Reyes-Moreno

Förderung

  • Cancer Research Society and the Canadian Institutes of Health Research
  • Cancer Research Society
  • Canadian Institutes of Health Research
  • Aligo Innovation
  • “Ministère de l’Économie et de l’Innovation”, Québec Government
  • Natural Sciences and Engineering Research Council of Canada (NSERC)

Zitieren

APA

Fortin, L., Girouard, J., Oufqir, Y., Paquin, A., Cloutier, F., Plante, I., Bérubé, G., & Reyes-Moreno, C. (2025). Inhibitory Impact of the Amino Benzoic Derivative DAB-2-28 on the Process of Epithelial–Mesenchymal Transition in Human Breast Cancer Cells. Molecules. https://doi.org/10.3390/molecules30153284

Vancouver

Fortin L, Girouard J, Oufqir Y, Paquin A, Cloutier F, Plante I, et al. Inhibitory Impact of the Amino Benzoic Derivative DAB-2-28 on the Process of Epithelial–Mesenchymal Transition in Human Breast Cancer Cells. Molecules. 2025. doi:10.3390/molecules30153284

BibTeX
@article{Fortin2025,
  author = {Fortin, Laurie and Girouard, Julie and Oufqir, Yassine and Paquin, Alexis and Cloutier, Francis and Plante, Isabelle and Bérubé, Gervais and Reyes-Moreno, Carlos},
  title = {Inhibitory Impact of the Amino Benzoic Derivative DAB-2-28 on the Process of Epithelial–Mesenchymal Transition in Human Breast Cancer Cells},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30153284}
}
Kostenlos starten →